CCA
LLY icon

Coign Capital Advisors’s Eli Lilly LLY Stock Holding History

Coign Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$765K Sell
832
-34
-4% -$34.5K 0.4% 49
2025
Q4 		$931K Buy
866
+11
+1% +$10.5K 0.49% 32
2025
Q3 		$652K Buy
855
+66
+8% +$49.1K 0.36% 60
2025
Q2 		$615K Buy
789
+18
+2% +$14K 0.42% 54
2025
Q1 		$637K Sell
771
-6
-0.8% -$4.99K 0.49% 44
2024
Q4 		$600K Buy
+777
New +$643K 0.55% 47

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Coign Capital Advisors's LLY Position: Q1 2026 in Review

Coign Capital Advisors reduced its Eli Lilly (LLY) stake by 3.9% in Q1 2026, selling an estimated $34.5K and leaving 832 shares worth $765K. The position accounts for 0.4% of the portfolio, ranked #49.

Coign Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $931K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Coign Capital Advisors held 832 shares of Eli Lilly worth $765K as of Q1 2026.
  • Coign Capital Advisors sold 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
  • Eli Lilly made up 0.4% of Coign Capital Advisors's portfolio in Q1 2026, its #49 holding.
  • Coign Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Coign Capital Advisors's Eli Lilly position peaked at $931K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Coign Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.